As of 2025-07-09, the EV/EBITDA ratio of Xiamen Amoytop Biotech Co Ltd (688278.SS) is 28.78. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 688278.SS's latest enterprise value is 28,046.13 mil CNY. 688278.SS's TTM EBITDA according to its financial statements is 974.63 mil CNY. Dividing these 2 quantities gives us the above 688278.SS EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 23.1x - 29.4x | 26.4x |
| Forward P/E multiples | 11.1x - 19.3x | 14.7x |
| Fair Price | 42.50 - 73.51 | 60.16 |
| Upside | -39.1% - 5.3% | -13.8% |
| Date | EV/EBITDA |
| 2025-06-13 | 29.89 |
| 2025-06-12 | 30.25 |
| 2025-06-11 | 30.15 |
| 2025-06-10 | 30.48 |
| 2025-06-09 | 30.34 |
| 2025-06-06 | 30.37 |
| 2025-06-05 | 30.77 |
| 2025-06-04 | 30.88 |
| 2025-06-03 | 30.97 |
| 2025-05-30 | 31.88 |
| 2025-05-29 | 33.39 |
| 2025-05-28 | 32.51 |
| 2025-05-27 | 32.01 |
| 2025-05-26 | 30.85 |
| 2025-05-23 | 30.77 |
| 2025-05-22 | 29.31 |
| 2025-05-21 | 28.91 |
| 2025-05-20 | 29.38 |
| 2025-05-19 | 29.98 |
| 2025-05-16 | 30.12 |
| 2025-05-15 | 30.05 |
| 2025-05-14 | 30.15 |
| 2025-05-13 | 30.42 |
| 2025-05-12 | 30.73 |
| 2025-05-09 | 30.45 |
| 2025-05-08 | 30.63 |
| 2025-05-07 | 30.46 |
| 2025-05-06 | 30.49 |
| 2025-04-30 | 30.65 |
| 2025-04-29 | 31.19 |
| 2025-04-28 | 30.65 |
| 2025-04-25 | 30.84 |
| 2025-04-24 | 30.94 |
| 2025-04-23 | 30.31 |
| 2025-04-22 | 32.60 |
| 2025-04-21 | 32.70 |
| 2025-04-18 | 31.25 |
| 2025-04-17 | 31.44 |
| 2025-04-16 | 31.97 |
| 2025-04-15 | 32.18 |
| 2025-04-14 | 32.21 |
| 2025-04-11 | 31.61 |
| 2025-04-10 | 31.28 |
| 2025-04-09 | 30.53 |
| 2025-04-08 | 30.60 |
| 2025-04-07 | 29.87 |
| 2025-04-03 | 32.34 |
| 2025-04-02 | 32.29 |
| 2025-04-01 | 32.43 |
| 2025-03-31 | 32.19 |